NO980473L - Anvendelse av flukonazol for å inhibere cancervekst - Google Patents

Anvendelse av flukonazol for å inhibere cancervekst

Info

Publication number
NO980473L
NO980473L NO980473A NO980473A NO980473L NO 980473 L NO980473 L NO 980473L NO 980473 A NO980473 A NO 980473A NO 980473 A NO980473 A NO 980473A NO 980473 L NO980473 L NO 980473L
Authority
NO
Norway
Prior art keywords
fluconazole
cancer growth
inhibit cancer
difluorophenyl
triazol
Prior art date
Application number
NO980473A
Other languages
English (en)
Other versions
NO980473D0 (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/674,180 external-priority patent/US5908855A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO980473D0 publication Critical patent/NO980473D0/no
Publication of NO980473L publication Critical patent/NO980473L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytisk preparat for behandling av cancere eller tumorer i pattedyr omhandles, som omfatter 2-(2,4-difluorfenyl)-l,3- bis(IH-l,2,4-triazol-l-yl)propan-2-ol og dens derivater. Et kjemoterapeutisk middel kan anvendes sammen med 2-(2,4- difluorfenyl)-l,3-bis(lH-l,2,4-triazol-l-yl)propan-2-ol og dens derivater, såvel som potensatorer. 2-(2,4- difluorfenyl)-l,3-bis(IH-l,2,4-triazol-l-yl)propan-2-ol og dens derivater kan også anvendes for å behandle virale infeksjoner, enten alene, sammen med andre anti-virale midler eller sammen med en potensator.
NO980473A 1995-08-04 1998-02-03 Anvendelse av flukonazol for å inhibere cancervekst NO980473L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US188995P 1995-08-04 1995-08-04
US08/674,180 US5908855A (en) 1996-07-16 1996-07-16 Compositions for treating viral infections
PCT/US1996/012474 WO1997005873A2 (en) 1995-08-04 1996-07-30 Use of fluconazole for inhibiting the growth of cancers

Publications (2)

Publication Number Publication Date
NO980473D0 NO980473D0 (no) 1998-02-03
NO980473L true NO980473L (no) 1998-04-03

Family

ID=26669622

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980473A NO980473L (no) 1995-08-04 1998-02-03 Anvendelse av flukonazol for å inhibere cancervekst

Country Status (18)

Country Link
EP (1) EP0841921A2 (no)
JP (1) JPH11510187A (no)
KR (1) KR19990036138A (no)
CN (1) CN1195288A (no)
AR (1) AR003175A1 (no)
AU (1) AU711966B2 (no)
BR (1) BR9609966A (no)
CA (1) CA2229024A1 (no)
CZ (1) CZ33798A3 (no)
HU (1) HUP9903420A3 (no)
IL (1) IL123095A0 (no)
MX (1) MX9800998A (no)
NO (1) NO980473L (no)
NZ (2) NZ315184A (no)
PL (1) PL324904A1 (no)
SK (1) SK14198A3 (no)
TR (2) TR199801739T2 (no)
WO (1) WO1997005873A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
FR2742405B1 (fr) * 1995-12-13 1998-02-27 Cgea Comp Gen Entre Auto Unite motrice susceptible d'etre accouplee a une enceinte roulante et vehicule resultant
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
KR20010103655A (ko) * 1998-11-09 2001-11-23 케네쓰 제이. 울코트 키메라 항-ｃｄ２０항체를 이용한 순환성 종양세포와관련된 혈액학적 악성종양의 치료법
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US7004915B2 (en) * 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
EP1895012A1 (en) 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2019185521A1 (en) * 2018-03-26 2019-10-03 Westfälische Wilhelms-Universität Münster Ergosterol-biosynthesis inhibitor and influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
TR199800270T1 (xx) 1998-05-21
AU711966B2 (en) 1999-10-28
CA2229024A1 (en) 1997-02-20
BR9609966A (pt) 1999-02-02
WO1997005873A3 (en) 1997-03-27
AR003175A1 (es) 1998-07-08
IL123095A0 (en) 1998-09-24
PL324904A1 (en) 1998-06-22
SK14198A3 (en) 1999-03-12
EP0841921A2 (en) 1998-05-20
AU6683396A (en) 1997-03-05
NZ503921A (en) 2002-03-01
NO980473D0 (no) 1998-02-03
MX9800998A (es) 1998-04-30
JPH11510187A (ja) 1999-09-07
KR19990036138A (ko) 1999-05-25
NZ315184A (en) 2000-05-26
HUP9903420A3 (en) 2001-12-28
TR199801739T2 (xx) 1998-12-21
WO1997005873A2 (en) 1997-02-20
CZ33798A3 (cs) 1998-06-17
CN1195288A (zh) 1998-10-07
HUP9903420A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
NO980473L (no) Anvendelse av flukonazol for å inhibere cancervekst
NO980419L (no) Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst
NO974694L (no) Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
MY116478A (en) Tri-substituted imidazoles having multiple therapeutic properties
FI97381C (fi) Menetelmä korkeaa verenpainetta alentavien substituoitujen pyrroli-, pyratsoli- ja triatsoliyhdisteiden valmistamiseksi
NO1997006I1 (no) Anastrozol/<alfa>,<alfa>,<alfa>',<alfa>'-tetrametyl-5(1H-1,2,4-triazol-1-ylmetyl)-m-benzendiatonitril
CA2292359A1 (en) Novel azalides and methods of making same
AU656138B2 (en) Process for foliar fungicide treatment and fungicide composition for implementing the process
IT1261173B (it) Composizione fungicide
NZ308391A (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
WO1997005870A3 (en) Use of griseofulvin for inhibiting the growth of cancers
NO986087L (no) Oralt preparat omfattende en antifungal triazolforbindelse
NO974696D0 (no) Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer
WO2001066551A8 (en) Azole compounds as therapeutic agents for fungal infections
IE831371L (en) 1,2,4-triazole derivatives
GB2278115B (en) 2-(2-Hydroxyphenyl)-1,3-pyrimidine derivatives and their use as stabilizers for coating compositions
ES8406191A1 (es) Procedimiento para la obtencion de un medio antiviral
MY107016A (en) Use of certain triazoles to protect materials from fungal attack, articles and compositions
NZ514859A (en) (-)-Enantiomer of 2-[2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione and microbicidal compositions thereof
YU46302A (sh) Supstituisani piroli
YU101291A (sh) Postupak za dobijanje triazolil-izopropanola
NO951808L (no) Fremgangsmåte ved fremstilling av enatiomert rene triazolylbenzotriazoler
WO2001079196A3 (en) 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
ES8704464A1 (es) Un procedimiento para la preparacion de derivados de imidazol.
MX9709712A (es) Uso de derivados de 1,2,4-triazol para la manufactura de un medicamento para el tratamiento de canceres.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application